Dyne Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
DYN•Inducement grants reported
Dyne Therapeutics, Inc. (NASDAQ: DYN) reported inducement grants under Nasdaq Listing Rule 5635(c)(4).
Related News
Elme Communities Provides Update On Liquidation Activities
ELME•
Hyatt Regency Dallas Names Lance Marrin General Manager
H•
Nektar Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
NKTR•
Brink’s expects Malaysia accounting change to cut revenue by about $100 million over next four quarters
BCO•
Insmed Chair and CEO William Lewis disposes of 10,700 common shares worth $1.14 million
INSM•